• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Tryptamines and derivatives

2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine (CAS No. 209169-05-1): A Comprehensive Overview

The compound 2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine, identified by the CAS registry number 209169-05-1, is a fascinating molecule with significant potential in various scientific and industrial applications. This compound belongs to the indole derivative family, a class of organic compounds known for their aromaticity and versatile reactivity. The indole ring system, characterized by a bicyclic structure consisting of a benzene ring fused to a pyrrole ring, forms the core of this molecule. The presence of a bromine atom at the 6-position of the indole ring introduces unique electronic and steric properties, making this compound particularly interesting for research and development in fields such as pharmacology, materials science, and organic synthesis.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of 2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine through various methodologies. One notable approach involves the use of palladium-catalyzed cross-coupling reactions, which allow for the precise introduction of functional groups onto the indole framework. For instance, researchers have successfully employed Suzuki-Miyaura coupling reactions to construct this compound by reacting an appropriate bromoindole derivative with a boronic acid-containing ethanamine fragment. This method not only ensures high yields but also provides excellent control over the regioselectivity of the product.

The structural features of 2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine make it an attractive candidate for applications in drug discovery. Indole derivatives are well-known for their ability to modulate various biological targets, including enzymes, receptors, and ion channels. The bromine substituent at the 6-position of the indole ring can act as an electron-withdrawing group, influencing the electronic properties of the molecule and potentially enhancing its bioactivity. Recent studies have demonstrated that this compound exhibits promising anti-inflammatory and antioxidant properties, suggesting its potential as a lead compound for therapeutic agents targeting inflammatory diseases.

In addition to its pharmacological applications, 2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine has shown promise in materials science. The indole moiety's aromaticity and conjugation make it suitable for use in organic electronics and optoelectronic devices. Researchers have explored its potential as a building block for constructing π-conjugated polymers and low-dimensional materials. For example, through controlled polymerization techniques, this compound has been incorporated into polymer frameworks that exhibit enhanced charge transport properties, making them candidates for next-generation organic semiconductors.

The synthesis and characterization of 2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine have been extensively studied using modern analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. These studies have provided detailed insights into its molecular structure, conformational flexibility, and supramolecular interactions. For instance, X-ray crystallographic analysis has revealed that the molecule adopts a specific conformation in the solid state due to hydrogen bonding interactions between the amine group and adjacent functional groups.

Furthermore, computational chemistry methods have been employed to investigate the electronic properties and reactivity of this compound. Density functional theory (DFT) calculations have provided valuable information about its frontier molecular orbitals, which are critical for understanding its chemical reactivity and potential applications in catalysis or energy storage systems. These computational studies complement experimental findings and provide a comprehensive understanding of the molecule's behavior under various conditions.

In conclusion, 2-(6-Bromo-1H-indol-3-yl)-N-methylethanamine (CAS No. 209169-05-1) is a versatile compound with diverse applications across multiple scientific disciplines. Its unique structural features, combined with recent advancements in synthetic chemistry and computational modeling, make it an invaluable tool for researchers seeking innovative solutions in drug discovery, materials science, and beyond. As ongoing research continues to uncover new properties and applications of this compound, its significance in both academic and industrial settings is expected to grow further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)